TSBXTurnstone Biologics Corp.

Nasdaq turnstonebio.com


$ 3.04 $ -0.02 (-0.66 %)    

Monday, 13-May-2024 15:59:37 EDT
QQQ $ 443.30 $ 1.02 (0.23 %)
DIA $ 394.89 $ -0.72 (-0.18 %)
SPY $ 521.24 $ 0.07 (0.01 %)
TLT $ 90.71 $ 0.23 (0.26 %)
GLD $ 217.89 $ -2.45 (-1.12 %)
$ 3.03
$ 3.12
$ 0.00 x 0
$ 0.00 x 0
$ 3.00 - $ 3.18
$ 1.63 - $ 13.20
100,976
na
69.73M
$ 6.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-22-2024 12-31-2023 10-K
3 11-10-2023 09-30-2023 10-Q
4 09-01-2023 06-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 turnstone-biologics-q1-eps-085-misses-078-estimate

Turnstone Biologics (NASDAQ:TSBX) reported quarterly losses of $(0.85) per share which missed the analyst consensus estimate of...

 turnstone-biologics-q4-eps-073-beats-086-estimate

Turnstone Biologics (NASDAQ:TSBX) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $...

 turnstone-biologics-q3-eps-100-up-from-615-yoy-cash-cash-equivalents-and-short-term-investments-1091m

Turnstone Biologics (NASDAQ:TSBX) reported quarterly losses of $(1.00) per share. This is a 83.74 percent increase over losses ...

 why-parazero-technologies-shares-are-trading-higher-by-over-100-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian re...

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 311 stocks hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

 top-4-health-care-stocks-that-could-lead-to-your-biggest-gains-in-q3

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 b-of-a-securities-initiates-coverage-on-turnstone-biologics-with-buy-rating-announces-price-target-of-18

B of A Securities analyst Geoff Meacham initiates coverage on Turnstone Biologics (NASDAQ:TSBX) with a Buy rating and announ...

 piper-sandler-initiates-coverage-on-turnstone-biologics-with-overweight-rating-announces-price-target-of-20

Piper Sandler analyst Joseph Catanzaro initiates coverage on Turnstone Biologics (NASDAQ:TSBX) with a Overweight rating and ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION